Tuesday, October 27, 2009
Not just IL-2 but an IL-2/Interferon Trial
In consulting with Dr. David I. Quinn of USC about using IL-2 on me, it turned out that Dr. Quinn is running a trial there to test the use of IL-2 with Interferon on otherwise healthy patients. Some previous trials have tried to temper the tough side-effects of IL-2 by combining it with some amount of Interferon. Studies show that patients taking IL-2 do better with their kidney removed first. We will probably go with this and they probably want to do it. It gives us one more thing to try leaving us the whole spectrum of the other six FDA approved medications afterwards. We will see Dr. Quinn on 11/16 for the consultation on this.
Subscribe to:
Post Comments (Atom)
When does this all start? And did you actually talk to Dr. Quinn(hopefully the last name means a good omen)or is Dr. Quinn telling your oncologist at ST. Judes all this?
ReplyDeleteDebbie
The St. Jude Tumor Board suggested Sutent but to consider IL-2. Dr. Sharma has not used IL-2 on kidney cancer. He called Quinn who we actually already had an appointment with for a 2nd opinion. Quinn suggests popping out that kidney like a champagne cork and filling me with fun toxic interferon & IL-2. Probably starting with the operation in late Nov.
ReplyDelete